ProstaGene's Unattributed - II Round

ProstaGene raised a round of funding on April 20, 2016.

ProstaGene is a biotechnology start up company that integrates proprietary molecular diagnostics with novel therapeutic screening and commercial experience in order to develop novel treatments for can…

Articles about ProstaGene's Unattributed - II Round: